Up to 20 percent of patients taking aspirin to lower the risk of suffering a second cerebrovascular event do not have an antiplatelet response from aspirin, the effect thought to produce the protective effect, researchers at the University at Buffalo have shown.
Many stroke, heart attack patients may not benefit from aspirinCourtesy EurekAlert! - Chemistry, Physics and Materials Sciences Sun, 02/24/2008 - 23:00
Reply |